Fintel reports that on December 19, 2024, B. Riley Securities upgraded their outlook for Cognition Therapeutics ...

On Friday, Cognition Therapeutics Inc (CGTX) stock saw a modest uptick, ending the day at $0.63 which represents no change from the prior close of of $0.63. The stock opened at $0.64 and touched a low ...

Cognition Therapeutics (CGTX) announced topline results from the exploratory Phase 2 ‘SHIMMER’ study demonstrating CT1812 ...

AI isn't just changing how we think—it's dissolving the boundaries between human and machine cognition in unexpected ways.

Researchers at the California Institute of Technology have unveiled a startling revelation about the human mind: our thoughts ...

Yet silence should be welcomed as an essential nutrient for the mind. Moments of silence allow for mental clarity, creativity ...

Researchers have uncovered important insights that could improve how mental health conditions are treated with brain stimulation therapy -- a treatment where electrical signals are used to stimulate ...

HYDERABAD: Silent night, holy nightAll is calm, all is brightRound yon Virgin, Mother and ChildHoly Infant so tender and mild ...

As the community of IT leaders and experts ponders the most likely future of technology, in which we outsource more and more ...

Cantor Fitzgerald has recently reduced Cognition Therapeutics Inc (CGTX) stock to Neutral rating, as announced on July 30, 2024, according to Finviz. Earlier, on November 3, 2021, Oppenheimer had ...

Two surprising findings from cognitive science demonstrate the strong impact of language and culture on financial decisions ...

The associations between fine particulate matter exposure and childhood cognitive performance depend on the individual chemicals and sources of exposure.